Agios to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ:AGIO) is set to present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2, 2020, at 2:00 p.m. ET. This event highlights Agios' commitment to advancing treatments in cancer and rare genetic diseases through its focus on cellular metabolism.

A live webcast will be available in the Investors section of the Agios website, with an archived replay accessible for two weeks post-presentation.

CAMBRIDGE, Mass., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Piper Sandler 32^nd Annual Virtual Healthcare Conference on Wednesday, December 2, 2020 at 2:00 p.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.

Contacts

Investors:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Associate Director, Corporate Communications
Jessica.Rennekamp@agios.com

FAQ

When is Agios Pharmaceuticals presenting at the Piper Sandler Conference?

Agios Pharmaceuticals is scheduled to present at the Piper Sandler 32nd Annual Virtual Healthcare Conference on December 2, 2020, at 2:00 p.m. ET.

How can I access the Agios Pharmaceuticals presentation?

The presentation can be accessed via a live webcast under the 'Events & Presentations' section on Agios' website.

Will the Agios Pharmaceuticals presentation be available later?

Yes, a replay of the Agios presentation will be archived on their website for at least two weeks after the event.

What is the focus of Agios Pharmaceuticals?

Agios Pharmaceuticals focuses on discovering and developing medicines for malignant hematology, solid tumors, and rare genetic diseases.

What are Agios Pharmaceuticals' current developments?

Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and preclinical development.